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Cloning and Crystal Structure
of Hematopoietic Prostaglandin D Synthase
Yoshihide Kanaoka,1,7 Hideo Ago,2,7 Eiji Inagaki,2 such as flushing, diarrhea, tachycardia, dyspnea, and
deep sleep (Roberts et al., 1980).Toyomichi Nanayama,2 Masashi Miyano,2
PGD2 is furtherconverted to9a,11b-PGF2, a stereoiso-Reiko Kikuno,3 Yutaka Fujii,4
mer of PGF2a, which exerts various pharmacological ac-Naomi Eguchi,5 Hiroyuki Toh,3
tions different from those induced by PGF2a (reviewedYoshihiro Urade,1 and Osamu Hayaishi1,6
by Smith et al., 1991). PGD2 is also readily dehydrated1Department of Molecular Behavioral Biology
in vitro (Fitzpatrick and Wynalda, 1983; Kikawa et al.,Osaka Bioscience Institute
1984) and in vivo (Hirata et al., 1988) to produce PGs ofOsaka 565
the J series, such as PGJ2, D12-PGJ2, and 15-deoxy-Japan
D12,14-PGJ2. 15-Deoxy-D12,14-PGJ2 was recently identified2Central Pharmaceutical Research Institute
as an endogenous ligand for a nuclear receptor (i.e.,Japan Tobacco Inc.
peroxisome proliferator-activated receptor g) and it pro-Osaka 569-11
motes adipocyte differentiation (Forman et al., 1995;Japan
Kliewer et al., 1995).3Biomolecular Engineering Research Institute
Hematopoietic PGD synthase (PGDS; EC 5.3.99.2),Osaka 565
previously termed the spleen-type PGDS (Urade et al.,Japan
1987) or glutathione (GSH)-requiring enzyme (Christ-4Department of Chemistry
Hazelhof and Nugteren, 1979), contributes to productionFukui Medical School
of PGD2 in the peripheral tissues (Ujihara et al., 1988a).Fukui 910-11
The enzyme is localized in antigen-presenting cells andJapan
mast cells of a variety of tissues (Urade et al., 1989,5PRESTO
1990) and is involved in the activation and differentiationJapan Science and Technology Corporation
of mast cells, since it is induced by c-kit ligand andOsaka 565
interleukin-3 in mouse bone marrow±derived mast cellsJapan
(Murakami et al., 1995). However, the structure and the
regulatory mechanism of expression of hematopoietic
PGDS remain to be elucidated.
Summary In this study, we cloned the cDNA for rat hematopoi-
etic PGDS, crystallized the recombinant enzyme, and
Hematopoietic prostaglandin (PG) D synthase is the determined the crystal structure at 2.3 AÊ resolution by
key enzyme for production of the D and J series of the multiple isomorphous replacement method. Molecu-
prostanoids in the immune system and mast cells. We lar evolutionary study revealed that this enzyme is a
isolated a cDNA for the rat enzyme, crystallized the re- vertebrate homolog of the sigma class glutathione
combinant enzyme, and determined the three-dimen- S-transferase (GST), which has previously been identi-
sional structure of the enzyme complexed with gluta- fied in invertebrates such as insects, cephalopods,
thione at 2.3 AÊ resolution. The enzyme is the first flukes, and nematodes. The crystal structure of hemato-
member of the sigma class glutathione S-transferase poietic PGDS complexed with GSH is proposed as the
(GST) from vertebrates and possesses a prominent structural determinant for recognition of the bulky sub-
cleft as the active site, which is never seen among strate, PGH2, which is isomerized to produce PGD2. This
other members of the GST family. The unique 3-D ar- paper reports the crystal structure of the enzyme that
chitecture of the cleft leads to the putative substrate utilizes PGH2, a common precursor of PGs (PGD2, PGE2,
binding mode and its catalytic mechanism, responsi- PGF2a), prostacyclin (PGI2), and thromboxane A2, as a
ble for the specific isomerization from PGH2 to PGD2. substrate.
Results and DiscussionIntroduction
cDNA Cloning and Expression of RatProstaglandin (PG) D2 is actively formed in a variety of
Hematopoietic PGDStissues (Ujihara et al., 1988a) and is involved in many
We designed twodegenerate primers for the rat enzyme:physiological events (reviewed by Ito et al., 1989; Hay-
a sense primer was predicted from LLYFNMRGRAEI inaishi, 1991). PGD2 promotes sleep; regulates body tem-
the N-terminal sequence of theenzyme and an antisenseperature, olfactory function, hormone release, and noci-
primer was from KPTLPFGK in lysylendopeptidase-ception in the central nervous system; prevents platelet
digested peptides. RT-PCR with rat spleenpoly(A)1 RNAaggregation; and induces vasodilation and bronchocon-
and those primers amplified a cDNA fragment of 134striction. It is also released from mast cells as an allergic
bp, which encoded a part of the amino acid sequenceand inflammatory mediator (Lewis et al., 1982) and is
of the purified enzyme. By 59-RACE and 39-RACE withresponsible for the symptoms in mastocytosis patients,
gene-specific primers from the sequence within the am-
plified fragment, the full-length cDNA (1004 bp) for the
enzyme was obtained. The cDNA encodes a protein com-6 To whom correspondence should be addressed.
7 These authors contributed equally to this work. posed of 199 amino acid residues with a calculated Mr
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In a phylogenetic tree, hematopoietic PGDS formed
a subcluster with members of the sigma class GST in-
cluding S-crystallins from cephalopods (Figure 2B). The
sigma class GSTs were previously reported in inverte-
brates, such as insects, cephalopods, flukes, and nema-
todes. Thus, hematopoietic PGDS is a novel vertebrate
homolog of the sigma class of the GST family.
Crystal Structure of Hematopoietic PGDS
The recombinant hematopoietic PGDS was crystallized
in a trigonal form. The three-dimensional structure was
determined at2.3 AÊ (R factor 5 20.4%and freeR factor 5
28.5% in the current model) by means of multiple heavy
atom isomorphous replacement phasing (Table 1). TheFigure 1. Tissue Distribution Profile of mRNA for Hematopoietic
crystal was obtained as a homodimer in an asymmetricPGDS
unit, and each monomer was complexed with a GSHTotal RNA (20 mg) from various rat tissues was electrophoresed in
molecule (Figure 3). The monomers were related by aa 1.2% agarose-2.2 M formaldehyde denaturing gel (lower panel).
The blot was probed with the 32P-labeled cDNAs for hematopoietic noncrystallographic 2-fold axis. The dimer interaction
PGDS (upper panel) and GAPDH (middle panel). shows the ªlock-and-keyº complimentarity feature of a
hydrophobic surface with a limited number of the elec-
trostatic interactions (Figures 3B and 3C), which is com-of 23,297. The first N-terminal methionine was cleaved
from the mature enzyme. The deduced amino acid se- monly observed in various GSTs except for sigma class
GST from squid (Ji et al., 1995).quence of the cDNA was identical with all of the deter-
mined amino acid sequence of the purified enzyme The dimension of hematopoietic PGDS monomer is
about 50 3 50 3 30 AÊ , and the overall folding motif is(more than 85% of the total sequence number).
The recombinant enzyme was expressed in the solu- the same as those of GSTs. The monomer is constructed
from two domains with a prominent interdomain cleftble fraction by E. coli and was purified by GSH-affinity
chromatography. The recombinant protein exerted both (Figure 4A); the N-terminal domain (amino acid residues
1±71) and the C-terminaldomain (82±199) are connectedPGDS (30 mmol/min/mg of protein) and GST (3 mmol/
min/mg) activities, which were essentially identical to by the residues 72±81 including two turn structures
(72±75 and 76±79). The N-terminal domain contains athose of the native enzyme purified from rat spleen (Ur-
ade et al., 1987). four-stranded b sheet and three a helices, arranged in
a bababba motif, in which the b2 and the b1 are parallel
and the b1 and the b3, and the b3 and the b4, areExpression of Hematopoietic PGDS mRNA
in Rat Tissues antiparallel. The a1 and a3 make the dimer interface
with the a4, a6, and a8 of the counterpart in the dimer.By Northern blot analysis, mRNA for the enzyme was
observed to be the most prevalent in rat spleen, followed The loop structure (46±52) bends at the position of P52
to the outside of the enzyme, which is the GSH bindingby the oviductÐweakly present in the thymus, bone
marrow, Peyer's patch, and ileumÐand not detectable site. The angle between the directions of the loop and
the b3 backbone is approximately 908, so that the sidein other tissues (Figure 1). The tissue distribution profile
was in good agreement with those profiles of the enzyme chains of the loop residues are exposed to the solvent
with a residue (I51) in cis-conformation, resulting in theactivity and immunoreactivity of hematopoietic PGDS
previously reported (Ujihara et al., 1988a; Urade et al., formation of a GSH-binding dimple. The C-terminal do-
main is composed of five a helices, in which the a4, a5,1989). Hematopoietic PGDS mRNA was also intensely
expressed in the oviduct, indicating that PGDS and its and a6 make an a-helix bundle. The long a5 bends at
the position of Q123. In the connecting loop of the a4product, PGD2, may play crucial, yet unknown, functions
in female genital organs. and a5, the backbone between S100 and W104 is kinked
to compensate for the a4, which is shorter than those
of other GSTs in the amino acid alignment (Figures 2AHomology of Hematopoietic PGDS with Members
of the GST Family and 4A).
GSH is bound to the side of the N-terminal domainA database search of the protein primary structure re-
vealed hematopoietic PGDS to be a member of the GST by forming two and eight hydrogen bonds to the atoms
of the protein backbone and side chain, respectively,family, as predicted by the partial amino acid sequence
analysis (Urade et al., 1989; Meyer and Thomas, 1995). similar to other GSTs (Figures 3D and 3E). The cysteinyl
backbone of GSH interacts with that of cis-I51 of theThe amino acid sequence of hematopoietic PGDS was
similar to those of all GST isozymes from the previously N-terminal domain via hydrogen bonds in an antiparallel
b-sheet manner. The amino nitrogen of g-glutamate ofknown five classes: alpha, mu, pi, sigma, and theta (Fig-
ure 2A), showing weak similarity (,30% identity) to GSH forms hydrogen bonds to both of the two carboxyl
oxygens of the D97 side chain of the other PGDS mole-mammalian GST isozymes, yet moderate similarity (32%
to 40% identity) to the insect and fluke GST, and the cule in the dimer. The Sg atom of GSH and the Oh of
Y8 show a hydrogen bonding distance of 3.1 AÊ (Figurehighest identity to GSTs of the house fly (Musca domes-
tica, 40% identity) and pig roundworm (Ascaris suum, 3E). All these residues are highly conserved among the
members of the GST family (Figure 2A).39% identity) in the multiple sequence alignment.
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Figure 2. Homology of Hematopoietic PGDS with Members of GST Family
(A) Alignment of amino acid sequences of rat PGDS and GSTs of various classes whose tertiary structures are known. The elements of
secondary structure are highlighted in pink (a helix) and green (b strand). Based on the coordinate data by the current work, amino acid
residues forming GSH- and putative PGH2 binding sites are marked by yellow and blue circles, respectively, on the top of the alignment. A
yellow diamond represents a residue in the counter monomer composing the GSH binding site. A green circle represents a residue interacting
with both GSH and PGH2. Amino acid sequences and the secondary structural information of GSTs were taken from SwissProt (sw) and
Protein Data Bank (PDB) (Bernstein et al., 1977). Squid sigma (gts_ommsl, sw; 1GSQ, PDB; (Ji et al., 1995), Rat mu (gtm1_rat, sw; 1GST, PDB)
(Ji et al., 1992), Human alpha (gta1_human, sw; 1GUH, PDB) (Sinning et al., 1993), Mouse pi (gtp1_mouse, sw; 1GLP, PDB) (GarcõÂa-SaÂ ez et
al., 1994), Fly theta (gtt1_luccu, sw) (Wilce et al., 1995).
(B) Unrooted phylogenetic tree of hematopoietic PGDS and GSTs from sigma, pi, mu, and alpha classes. Amino acid sequences of GSTs
from rats, Drosophila melanogaster, and Schistosoma mansoni were selected as representatives for mammals, insects, and flukes to simplify
the phylogenetic analysis. House fly GST of the sigma class was also included to see the evolutionary relationship between these two species
of fly. Partial sequence data, redundant entries, and highly similar sequences (.90% identity to an already included entry) were excluded.
One representative sequence was included from GSTs and S-crystallins of squid/octopus because they were monophylic in the preliminary
clustering analysis. A multiple sequence alignment was constructed among hematopoietic PGDS and 21 members of GSTs from the four
classes (sigma, pi, mu, and alpha) because the sequence identities of the theta class GSTs to the other classes of GSTs were too weak (ca.
20%) to obtain a reliable alignment. The amino acid sequences were taken from the sequence databases SwissProt (sw), PIR, and GenBank
(gb): House fly (mdu02616, gb), Fruit fly (GTS2_DROME, sw), O. volvulus (S40165, PIR), C. elegans Sigma (cet26c5, gb), Pig roundworm
(S38626, PIR), Blood fluke 28kD (GT28_SCHMA, sw), Squid S-crystallin (SC11_OMMSL, sw), Squid GST (GTS_OMMSL, sw), D. immitis (diu14753,
gb), C. elegans Pi (GTP_CAEEL, sw), Rat 7±7 (GTP_RAT, sw), Blood fluke 26kD (GT26_SCHMA, sw), Blood fluke 27kD (GT27_SCHMA, sw),
Rat Yb4 (B29231, PIR), Rat Yb1 (GTM1_RAT, sw), Rat Yb2 (GTM2_RAT, sw), Rat Yb3 (GTM3_RAT, sw), Rat Ya (GTA1_RAT, sw), Rat Yc1
(GTC1_RAT, sw), Chicken (S43431, PIR), Rat 8±8 (GTA3_RAT, sw).
Catalytic Pocket of Hematopoietic PGDS W104 forms a ceiling on the C-terminal domain, since
the indole ring is directed parallel to the a4 extendedThe prominent cleft including the GSH binding site be-
tween the two domains is presumed to be the catalytic by the kinked backbone including W104 (Figures 4A and
4B). Pocket 1 has a path to a branched cavity consistingpocket (Figures 4A and 4B). The interdomain cleft ex-
pands to a wide and deep pocket (pocket 1) behind the of another pocket (pocket 2) and a narrow tunnel. Pocket
1 also opens to the other pocket (pocket 3) on the outerGSH binding site with the longest loop eaves of the a4
and a5. At the entrance of pocket 1, the indole ring of surface due to the short C-terminal end of hematopoietic
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Table 1. Crystallographic Data
Space group P3121
Cell dimensions a 5 b 5 56.5 AÊ c 5 233.4 AÊ a 5 b 5 908 g 5 1208
Z 12
VM 2.2
Statistics of Reflection Data
Native Thimerosal K2PtCl4 Native
Raxis IIC Raxis IIC Raxis IIC KEK/PF
Data
resolution 40.±2.7 AÊ 40.±3.0 AÊ 40.±3.0 AÊ 40.±2.3 AÊ
Reflections
measured/unique 55,948/12,129 69,342/9,259 39,341/8,282 77,899/19,065
Completeness
overall/outer shell 95.8%/93.4% 97.9%/95.4% 88.7%/79.8% 95.1%/87.0%
Rmergea
overall/outer shell 5.7%/20.5% 11.6%/37.3% 9.8%/96.4% 8.5%/28.0%
Risob Ð 22.7% 26.5% Ð
Statistics of the MIR Phasing
Data
resolution 40.±4.0 AÊ 40.±4.0 AÊ 40.±4.0 AÊ
Rcullisc 0.468 0.593
Rkrautd 0.117 0.243
Phasing power
mean/outer shell 2.49/1.96 1.16/1.02
Mean figure of merit
of MIR phasing 0.664 (3725 phased reflections)
of phase improvement and extension 0.922 (5805 phased reflections: up to 3.5 AÊ )
Statistics of the Refinement
Resolution 6.0±2.3 AÊ
Reflections (|F| $ 2.0s) 17,811
Rvaluee 20.4%
Rfreee 28.9%
RMSD
in bond lengths 0.01 AÊ
in bond angles 1.6138
No. of atoms (nonhydrogen) 3,336
No. of solvent atoms 99
Ramachandran plotf
Most favored 93.9%
Allowed 5.8%
aRmerge 5 S (|I 2 ,I.|)/S(I)
bRiso 5 S (|IP 2 |PH|)/S(IP)
cRcullis 5 S | | FPH(obs) 1/2 FP(obs) | 2 FH(calc)|/S|FPH(obs) 1/2 FP(obs) | with the sum taken over all centric reflections.
dRkraut 5 S | | FPH(obs) | 2 | FPH(calc) | | /S IFPH(obs) with the sum taken over all acentric reflections.
eRvalue 5 S | F(obs) 2 F(calc)|/S|Fobs |, Rfree is the free Rvalue (10% random data subset)
fRamachandran plot quality assessment using PROCHECK.
PGDS. There is a straight path from the outside of the v chain 10 AÊ long, and an a chain 8 AÊ long, when it
takes the extended conformation (Figures 4C and 5).protein to pocket 2 via pocket 3 and pocket 1 (Figure 4B).
As for the dimension of the cavities, pocket 1 is 5 AÊ When the reactive O±O bridge in PGH2 is placed near
the Sg atom of the bound GSH, the charged carboxylatein depth by 6 AÊ in width and opens to the GSH binding
site. Pocket 2 is 4 AÊ in depth and 6 AÊ in width and is in the a chain is adapted to the hydrophilic pocket 2,
and the hydrophobic v chain to the hydrophobic pocketlined with hydrophilic residues in contrast to pockets
1 and 3, whose surfaces are hydrophobic with many 3, without any interposition. The indole ring of W104
seems to play important roles in the substrate bindingaromatic side chains. In the bottom of pocket 2, two
bound water molecules are found 2.9 AÊ apart, and they in terms of making the cleft wide open and forming
hydrophobic interactions with the cyclopentane head ofform hydrogen bonds toOh of Y152 and Nz of R14, which
are at the distances of 8.7 AÊ and 8.1 AÊ , respectively, from the substrate.
the Sg atom of GSH. The electrostatic potential on the
surface within the cleft including GSH was positive Catalytic Mechanism of Hematopoietic PGDS
The catalytic reaction of hematopoietic PGDS is postu-around the guanidino group of R14, negative along GSH,
and neutral in the other part. lated from the PGH2 binding model (Figure 5). The hydro-
gen bonding of the Sg atom of bound GSH to the OhBased on the feature of the cleft, the binding mode
of the substrate, PGH2, was proposed. PGH2 is com- atom of Y8 is considered to decrease the pKa of the thiol
group, resulting in a deprotonated anion S2 at neutral pHposed of a 6 AÊ spherical head group with two tails, an
Cloning and Structure of Prostaglandin D Synthase
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Figure 3. Crystal Structure of Homodimer of Hematopoietic PGDS
(A) Stereo Connolly surface of hematopoietic PGDS dimer complexed with GSH in CPK model. Oxygen, nitrogen, carbon, and sulfur atoms
of GSH are colored red, blue, green, and yellow, respectively.
(B) Ribbon diagram of hematopoietic PGDS dimer including bound GSH in CPK model. The dimer interface is composed of a hydrophobic
side chain (F48) from one monomer and a hydrophobic cavity on the other (shown in ball and stick models with the dot surface). The
hydrophobic cavity is formed by V91, T94, L127, D130, L131, Y134, and F141.
(C) Closed-up view of the dimer interface in stereo. The electron density shows the difference Fourier map with omission of the side chains
of F48, V91, T94, L127, D130, L131, Y134, and F141.
(D) GSH difference Fourier map using the final hematopoietic PGDS model omitted GSH molecule.
(E) GSH interaction diagram. The hydrogen bonds between the bound GSH and hematopoietic PGDS are shown by the break lines with their
distances. The residues of D979 belongs to the counterpart in the dimer.
Cell
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Figure 4. Catalytic Pocket of Hematopoietic PGDS Complexed with GSH and a Proposed PGH2 Binding Model
(A) Cleft view of hematopoietic PGDS monomer and bound GSH. The putative substrate binding cleft is shown as a cartoon model with
Connolly surface. The kinked region after a4 from S100 to W104 is shown in pearl. C-terminal L199 is colored light green. Bound GSH is
shown in CPK model.
(B) Horizontal cross section view of the cleft shown in (A). The cleft is composed of three pockets. Pocket 1 opens to bound GSH in atomic
colored stick model with indole ring of W104 (pink) on the ceiling as well as to pockets 2 and 3.
(C) Model of PGH2 binding in the catalytic pocket. PGH2 (ball and stick model) was placed in the cleft taking account of the pocket environment
and the distance between the thiolic S atom of GSH and the oxygen atoms of PGH2. The conformation of a and v chains of PGH2 was adjusted
to the surface of hematopoietic PGDS by means of tortional rotation of single bonds in these hydrocarbon chains using an energy-minimized
PGH2 model.
as a reactive specimen of base attack, as reported in product, PGD2, and recycling of GSH in net without con-
the cases of other GSTs (Ji et al., 1994; Wilce et al., sumption of GSH (Figure 5-4).
1995; BjoÈ rnestedt et al., 1995). When PGH2 binds to the
cleft in hematopoietic PGDS (Figure 5-1), the isomeriza-
Comparison of Catalytic Pockets of Hematopoietiction reaction is initiated by the nucleophilic attack of the
PGDS and Other GSTsthiolic anion of the deprotonated GSH as an activated
Hematopoietic PGDS catalyzes the isomerization ofspecimen to the oxygen atom of PGH2 (Figure 5-2). The
PGH2 to PGD2 in a highly specific manner (Urade et al.,nucleophilic attack results in forming an adduct of GSH
1987), whereas all other GSTs catalyze the conversionand PGH2, and the successive base attack on the hydro-
of PGH2 to three products: the other regio-isomer ofgen atom to the C-11 by GS2 in solution causes O-S
PGD2, PGE2, and its further reduced product, PGF2a, inbond cleavage to form the C-11 carbonyl in a concerted
major part, and PGD2 in the least amount (Ujihara etmanner (Figure 5-3). The hydrogen transfer to C-9 hy-
droxy anion from GSH completes the formation of the al., 1988b). The catalytic efficiency and specificity of
Cloning and Structure of Prostaglandin D Synthase
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Figure 5. Reaction Mechanism of Isomeriza-
tion from PGH2 to PGD2 by Hematopoietic
PGDS
A schematic drawing of the catalytic pocket
of hematopoietic PGDS with PGH2 shown in
the same direction as in Figure 4B (panel 1).
Pockets 1, 2, and 3 are colored yellow, blue,
and green, respectively. The thiolate anion of
bound GSH attacks the oxygen at C-11 of
PGH2 (panel 2). The putative reaction interme-
diate of PGH2 with GSH is attacked by a cer-
tain base like bulk GSH in solvent (panel 3)
to produce PGD2 in a sterically restricted
manner (panel 4).
hematopoietic PGDS is ascribed to the structural char- The aromatic residues around bound GSH, other than
acteristics of the catalytic pocket. In fact, the cleft of the Tyr residue forming a hydrogen bond to Sg of GSH,
hematopoietic PGDS was found to be unique and quite are suggested to function as acceptors for hydrophobic
different from those of other GSTs (Figure 6). substrates in each GST (Ji et al., 1993; GarcõÂa-SaÂez et
Hematopoietic PGDS possesses a continuous cavity al., 1994; Ji et al., 1995; Cameron et al., 1995). The cleft
from pocket 3 on the enzyme surface to pocket 2 in the characteristics of GSTs and hematopoietic PGDS are
bottom via pocket 1 (Figures 4B and 6A9), whereas other represented by the geometry of the nearest aromatic
GSTs have shallow and narrow cavities. The cleft of residue (Figures 6A±6E) as a putative substrate acceptor
squid sigma class GST has the shallowest pocket with facing to thebound GSH (Figure6F). W104 in hematopoi-
a narrow entrance among GSTs (Figure 6B; Ji et al., etic PGDS is directed parallel to the GSH backbone,
1995: 1GSQ), in which F98 is exposed to the position whereas the aromatic rings of the Tyr or Phe residue
corresponding to pocket 1 of hematopoietic PGDS, and of all other GSTs except for alpha class are directed
R13, F106, and F202 are located at the entrance of the perpendicular to the vertical aspect of GSH. F222 of the
pocket 1, resulting in narrow entrances. In the mu and C terminus in alpha class GST is perpendicular to the
pi class GSTs (mu, Raghunathan et al., 1994: 1HNA; pi, horizontal aspect of GSH (Sinning et al., 1993). The dif-
Reinemer et al., 1991: 1GSR), the aromatic side chains, ferent cleft architecture of alpha class enzymes seems
Y115 and Y106, make narrow the entrance of the pocket to contribute to the higher efficiency of PGH2 conversion
1, and the side chains of R107 and R98 occupy the than that found for mu or pi class enzymes (Ujihara et
position corresponding to pocket 2 of hematopoietic al., 1988b). It is also noteworthy that the alpha class
PGDS, respectively (Figures 6C and 6D). In the mu class GST is distant from GSTs of other classes in the phyloge-
GST, a long loop structure connecting b2 and a2 (Figure netic tree and that hematopoietic PGDS is far from other
2A) also narrows the entrance of the pocket 1. In the members of the diverse sigma class enzymes (Figure 2B).
alpha class GST (Sinning et al., 1993: 1GUH), the side
chains of R15, E104, and L107 are exposed to inside
Concluding Remarksthe cleft, and the side chains of L107 and R15 close the
The recombinant hematopoietic PGDS was crystallizedentrance of the pocket 2 to divide it from the GSH bind-
and the three-dimensional structure complexed withing site (Figure 6E). In the mu, pi, and alpha classes of
GSH was determined. The evolutionary study and theGST, the extra long C termini (Figure 2A) are also located
crystal structure analysis revealed that hematopoieticat the entrance of the pocket 1. There is no pocket 3
PGDS is a sigma class GST. However, a prominent cleftin any other GSTs. Conclusively, hematopoietic PGDS
near the bound GSH was found to be unique and distin-possesses the deepest and widest cleft among GSTs,
guished it from other GSTs. The features of the cleftwhich appears to play an essential role in the efficiency
and the specificity of the enzyme activity. suggest the putative PGH2 binding mode and provide
Cell
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Figure 6. Comparison of Substrate Binding Cleft between Hematopoietic PGDS and Other GSTs
(A±E) Connolly surfaces of the substrate binding clefts of hematopoietic PGDS (A, A9; colored white in F), sigma (B; blue in F) (Ji et al., 1995:
1GSQ), and mu (C; green in F) (Raghunathan et al., 1994: 1HNA), pi (D; yellow in F) (Reinemer et al., 1991: 1GSR), and alpha (E; pink in F)
(Sinning et al., 1993: 1GUH) class GSTs are shown in the same views of the superimposed models. Pockets 1, 2, and 3 of the cleft of
hematopoietic PGDS are shown in (A9). The side chains of GSTs which stick into the cleft at the position corresponding to pockets 1 and 2
are shown as ball and stick models in (B) to (E). The putative substrate binding cleft of hematopoietic PGDS is deeper and wider than the
corresponding clefts of the other GSTs. The Tyr residue forming a hydrogen bond to Sg of GSH is colored yellow, and the aromatic amino
acid facing to GSH binding site in pink. (F) Schematic diagram of the direction of the aromatic amino acids in the catalytic site in stereo. Each
arrow shows the most plausible direction of substrate approach.
Experimental Proceduresinsight into the PGH2-PGD2 isomerase mechanism. The
tertiary structure of PGDS gives informative clues for
Amino Acid Sequence Analysisthe development of specific inhibitors in order to clarify
Rat hematopoietic PGDS was purified as described previously (Ur-
the enzyme functions in vivo in terms of mast cell activa- ade et al., 1987). The purified enzyme (300 mg) was incubated with
tion, cell growth control, adipogenesis, and female geni- lysylendopeptidase (Sigma, St. Louis) or Staphylococcus aureus V8
protease (Pierce, Rockford, IL) at 308C for overnight. The peptidetal function.
Cloning and Structure of Prostaglandin D Synthase
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fragments were then separated by HPLC. The amino acid sequence The GST activity was measured with 1-chloro-2,4-dinitrobenzene
used as substrate (Habig et al., 1974).of the peptides was determined with a 477A protein sequencer
and an on-line 120A PTH analyzer (Perkin-Elmer, Foster, CA). The
C-terminal amino acid sequence was determined after incubation Evolutionary Analysis
of the purified enzyme with carboxypeptidase Y (Pierce) by the Databases SwissProt rel. 32.0, PIR rel. 46.0, and GenBank rel. 91.0,
method of Klemm (1982). were searched for amino acid sequences similar to that of rat hema-
topoietic PGDS by FASTA and TFASTA programs in GCG software
package ver. 8.1 (Devereux et al., 1984). The amino acid sequencesRT-PCR
were aligned by PILEUP program in GCG and refined visually toTotal RNAwas extracted from rat spleen homogenate by the method
increase the sequence similarities. Gaps interrupting the secondaryof Chomczynski and Sacchi (1987), and the poly(A)1 RNA was puri-
structural elements were excluded as much as possible. Percentfied by Oligotex-dT30 chromatography (Takara Shuzo, Shiga, Ja-
identities between the sequences were obtained from the multiplepan). cDNAs were synthesized by Moloney murine leukemia virus-
sequence alignment. Molecular phylogeny was analyzed by PHYLIPreverse transcriptase after annealing poly(A)1 RNA (1 mg) from rat
software package ver. 3.5c (Felsenstein, 1993). All the alignmentspleen with oligo-dT primer. PCR amplification with degenerate
sites containing gaps were excluded for the construction of theprimers (a sense primer, 59-CTICTITACTTCAA(C/T)ATG(A/C)GIGGIA
phylogenetic tree. The distance between each pair of the alignedGIGCIGAAAT-39 and an antisense primer, 59-TTICC(A/G)AAIGGI
sequences was calculated by PROTDIST program in PHYLIP withA(A/G)IGTIGGTTT-39) was conducted in a GeneAmp PCR System
an amino acid substitution model, PAM001 (Dayhoff et al., 1978;2400 (Perkin-Elmer) using the following program: 948C for 30 s, 458C
Felsenstein, 1996). Based on the distance, an unrooted phylogeneticfor 30 s, and728C for 60 s for 30 cycles. The amplifiedcDNA fragment
tree was constructed by the neighbor-joining method (Saitou andwas cloned into pCR-Script vector (Stratagene, La Jolla, CA) and
Nei, 1987) with the NEIGHBOR program in PHYLIP. The bootstrapsequenced. A rat spleen cDNA library was prepared using a Mara-
probability was calculated at each node by reproducing 1000 boot-thon cDNA amplification kit (Clontech, Palo Alto, CA). The cDNA
strap samples with SEQBOOT andCONSENSE programs in PHYLIP.library was used for the 39-RACE and 59-RACE reaction with gene-
specific primers (a sense primer, 59-ATAGAACAAGCTGACTGGCCT
Crystallization and Preparation of Heavy Atom DerivativesA-39 and an antisense primer 59-TAGGCCAGTCAGCTTGTTCTAT-39).
Recombinant enzyme was crystallized by the hanging drop vaporThe reaction mixture contained 0.8 mM dNTP, gene-specific primer
diffusion method at 22.58C. The protein solution (7.3 mg/ml in 50(50 pmol), adapter primer (10 pmol), 1 ml of 10 times-diluted cDNA
mM Tris-HCl [pH7.5] containing 10 mM GSH) was mixed with anlibrary, and 2.5 units Pfu DNA polymerase in a total volume of 50
equivolume of a reservoir solution containing 18% (w/v) PEG6000,ml of the Pfu buffer (Stratagene). The reaction was conducted using
100 mM ammonium citrate (pH 5.0), 5 mM CaCl2, 10 mM DTT, andthe following program: 948C for 30 s, 608C for 30 s, 728C for 60 s
2% (v/v) 1,4-dioxane. The mixture (4 ml) was equilibrated againstfor 30 cycles followed by 5 min at 728C. The DNA sequence was
the reservoir solution (1 ml). Crystals were grown in the dimensiondetermined with a LI-COR model 4000L automated DNA sequencer
of 0.2 3 0.15 3 0.1 mm within three weeks, and they belong to the(LI-COR Inc., Lincoln, NE) after cycle sequencing with a SequiTherm
trigonal space group P3121 with the cell dimensions a 5 b 5 56.5 AÊcycle sequencing kit (Epicentre Technologies, Madison, WI).
and c 5 233.4 AÊ and one dimer per asymmetric unit with a Matthews'
coefficient of 2.2 AÊ 3/Da (Matthews, 1968). Crystals were soaked in
Northern Blot Analysis
the reservoir solution without DTT containing 1 mM thimerosal or
Various tissues of adult rats (Sprague-Dawley) were homogenized
K2PtCl4 for one day at 22.58C for preparation of heavy atom deriva-in Isogen solution (Nippon Gene, Toyama, Japan). Total RNA (20
tives.
mg) was denatured in formamide/formaldehyde, electrophoresed in
1.2% agarose-2.2 M formaldehyde gel, and transferred to a Biodyne
Data Collection and Processingmembrane (Pall Ultrafine Filtration, Glen Cove, NY). After prehybrid-
Diffraction data were collected with a Rigaku R-Axis IIC on a Rigakuization at 428C for 2 hr in 53 SSC, 53 Denhardt's solution, 50%
RU-H3RHF generator (46 kV/86 mA) with a nickel filter and an asym-formamide, 0.2% SDS, and 100 mg/ml denatured salmon sperm
metric focusing mirror system (CuKa 5 1.5418 AÊ ). Collected imagesDNA, the blot was hybridized at 428C for 16 hr with a 32P-labeled
were processed with Denzo (Otwinowski, 1993). Diffraction data forcDNA fragment prepared with a Megaprime labeling kit (Amersham,
the structure refinement was also collected by screenless Weis-Buckinghamshire, UK). The blot was washed once in 23 SSC and
senberg camera at BL6A2 Photon Factory in Tsukuba, Japan (Sa-0.1% SDS at room temperature, twice for 30 min in 0.23 SSC and
kabe, 1991). Two imaging plates (200 3 400 mm) were exposed in0.1% SDS at 508C, and then exposed at 2808C to Kodak XAR film
each frame at 430 mm of crystal-detector distance. Images werewith an intensifying screen.
scanned on a Fuji Film BAS2000 and processed using a modified
WEIS program (Higashi, 1989; Fields et al., 1992) and CCP4 pro-
Expression and Purification of Recombinant Enzyme grams for scaling and merging (The CCP4, 1994). The statistics of
NdeI and EcoRI restriction sites were created by PCR at the initiating the collected data are shown in Table 1.
ATG and downstream of the stop codon of the cDNA, respectively.
The amplified fragment (z600 bp) containing the entire coding re- Phasing, Model Building, and Refinement
gion was inserted into pT7±7 vector (Tabor and Richardson, 1985) The structure was determined by the method of multiple isomor-
and introduced into E. coli BL21 (DE3). The transformant was grown phous replacement (MIR). PHASES was used for the relative scaling
to log phase in LB-ampicillin (50 mg/ml) medium and cultured for a between native and derivative data, refinement of heavy atom posi-
further 6 hr in the presence of 0.4 mMisopropyl-b-D-thiogalactoside. tions, density modification and phase extention, and phase calcula-
The cells were pelleted and sonicated in 20 ml of phosphate-buf- tion (Furey and Swaminathan, 1990). Heavy atom positions of thi-
fered saline (PBS) with a Branson model 350 Sonifier (Branson Sonic merosal were determined by Shelxs86 (Sheldrick, 1985). Pt sites
Power Co., Danbury, CT). The homogenate was centrifuged at were searched by means of cross difference Fourier technique using
10,000 3 g for 10 min. The resultant supernatant was incubated with thimerosal phase. Absolute handness was determined by the differ-
GSH-Sepharose 4B (1 ml; Pharmacia Biotech, Uppsala, Sweden) in ence Fourier of the platinum and native data using anomalous contri-
PBS containing 1% Triton X-100 at 48C for 3 hr ona rotating platform. bution of the thimerosal derivative (Blundell and Johnson, 1976).
After sequential washing of the resin with PBS containing 1% Triton MIR phases (Table 1) were calculated at 4.0 AÊ (mean figure of merit
X-100 followed with PBS, the enzyme was eluted in 50 mM Tris- of 0.664 for 3725 unique reflections), and phase improvement by
HCl (pH 7.5) and 10 mM GSH. solvent flattening and phase extension from 4.0 to 3.5 AÊ were ap-
plied. Improved electron density map was interpretable and built
whole model except for the residues from 29 to 50. These residuesEnzyme Assay
The PGDS activity was determined in 50 ml of 0.1 M Tris-HCl (pH were traced in the original MIR map because the electron density
of this region was truncated in the modified map. During the tracing8.0), containing 1 mM GSH at 258C for 1 min after addition of [1±
14C]PGH2 (final 40 mM) as described previously (Urade et al., 1987). of polypeptide chains, the structures of the homologous GSTs were
Cell
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referred. Built model was refined by XPLOR (BruÈnger, 1992) with Devereux, J., Haerberli,P., and Smithies,O. (1984). A comprehensive
set of sequence analysis programs for VAX. Nucleic Acids Res. 12,Raxis data from 8.0 to 3.1 AÊ (R-value 5 22.7%). The successive
refinement and the further rebuilding using synchrotron data (6.0- 387±395.
2.3 AÊ ) were applied using XPLOR and O (Jones et al., 1991). During Felsenstein, J. (1993). PHYLIP (Phylogeny Interface Package) ver-
iterative refinement and model-rebuilding, 99 waters and two GSH sion 3.5c. Distributed by theauthor. Department of Genetics, Univer-
molecules were included. The structural quality was verified by PRO- sity of Washington, Seattle.
CHECK (Laskowski et al., 1993) in CCP4. Final R factor and free R Felsenstein, J. (1996). Inferring phylogenies from protein sequences
factor were 20.4% and 28.9%, respectively. The rms deviations of by parsimony. Distance and likelihood methods. In Methods in Enzy-
atomic bond lengths and angles were 0.01 AÊ and 1.6138, re- mology, R.F. Doolittle, ed. (San Diego, CA: Academic Press), vol.
spectively. The statistics of the refined model are summarized in 266, pp. 418±427.
Table 1. The atomic coordinates of hematopoietic PGDS will be
Fields, B.A., Guss, J.M., Lawrence, M.C., and Nakagawa, A. (1992).deposited in the Protein Data Bank (Brookhaven National Labora-
The Weissenberg method for the collection of X-ray diffraction datatory, Upton, NY).
from macromolecular crystals: modifications to the data-processing
program WEIS. J. Appl. Cryst. 25, 809±811.
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